MML Investors Services LLC Purchases 4,576 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

MML Investors Services LLC lifted its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 17.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 30,455 shares of the real estate investment trust’s stock after acquiring an additional 4,576 shares during the quarter. MML Investors Services LLC’s holdings in Omega Healthcare Investors were worth $1,240,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in OHI. Daiwa Securities Group Inc. lifted its holdings in shares of Omega Healthcare Investors by 317.7% in the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock worth $160,739,000 after acquiring an additional 3,003,845 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Omega Healthcare Investors by 328.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,661,964 shares of the real estate investment trust’s stock worth $67,642,000 after acquiring an additional 1,274,238 shares during the last quarter. Marshall Wace LLP bought a new stake in shares of Omega Healthcare Investors in the 2nd quarter worth about $20,962,000. FMR LLC lifted its holdings in shares of Omega Healthcare Investors by 9.9% in the 3rd quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock worth $171,625,000 after acquiring an additional 380,626 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in Omega Healthcare Investors by 7.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock valued at $127,831,000 after buying an additional 272,299 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Down 3.4 %

Shares of Omega Healthcare Investors stock opened at $37.99 on Thursday. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. The company has a market cap of $10.26 billion, a P/E ratio of 27.93, a PEG ratio of 1.22 and a beta of 0.98. The firm’s 50 day moving average price is $40.33 and its 200-day moving average price is $38.07. Omega Healthcare Investors, Inc. has a 52-week low of $27.53 and a 52-week high of $44.42.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were paid a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 annualized dividend and a dividend yield of 7.05%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 197.06%.

Insider Buying and Selling

In related news, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. The trade was a 10.96 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. The trade was a 36.19 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

OHI has been the subject of a number of research analyst reports. BMO Capital Markets upgraded shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price objective for the company in a report on Monday, December 9th. Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Truist Financial lifted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Scotiabank lifted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Finally, BNP Paribas upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective for the company in a report on Thursday, October 31st. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Omega Healthcare Investors presently has an average rating of “Moderate Buy” and a consensus target price of $40.18.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.